Zevia PBC (NYSE:ZVIA) Issues Earnings Results

Zevia PBC (NYSE:ZVIAGet Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01), FiscalAI reports. Zevia PBC had a negative net margin of 4.11% and a negative return on equity of 13.43%. The business had revenue of $45.00 million during the quarter, compared to the consensus estimate of $44.21 million.

Zevia PBC Price Performance

Shares of NYSE ZVIA traded down $0.01 during mid-day trading on Wednesday, reaching $1.72. 318,060 shares of the company’s stock traded hands, compared to its average volume of 865,024. Zevia PBC has a 1-year low of $1.11 and a 1-year high of $3.63. The stock has a market cap of $132.02 million, a P/E ratio of -17.15 and a beta of 0.99. The business has a 50-day simple moving average of $1.57 and a 200 day simple moving average of $1.49.

Insider Buying and Selling

In related news, major shareholder De Depot Et Placement D. Caisse sold 2,150,000 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $1.90, for a total transaction of $4,085,000.00. Following the completion of the transaction, the insider owned 11,400,428 shares in the company, valued at approximately $21,660,813.20. This represents a 15.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 7.70% of the company’s stock.

Institutional Trading of Zevia PBC

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Quadrature Capital Ltd bought a new position in Zevia PBC in the fourth quarter valued at about $26,000. Engineers Gate Manager LP bought a new stake in shares of Zevia PBC in the 4th quarter worth about $28,000. The Manufacturers Life Insurance Company bought a new stake in shares of Zevia PBC in the 4th quarter worth about $38,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Zevia PBC during the 3rd quarter valued at about $44,000. Finally, JPMorgan Chase & Co. raised its position in shares of Zevia PBC by 2,460.7% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,518 shares of the company’s stock valued at $50,000 after buying an additional 14,912 shares in the last quarter. Institutional investors own 53.21% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Zevia PBC from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 17th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $4.42.

Get Our Latest Research Report on ZVIA

Zevia PBC Company Profile

(Get Free Report)

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.

Featured Stories

Earnings History for Zevia PBC (NYSE:ZVIA)

Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.